- A Case of Spontaneous Regression of Small Cell Lung Cancer
-
Hong GY, Park JS, Ruy SS, Kang SJ, Woo YA, Kang MW, Lim YK, Yeo HS, Kim HN
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1294-1298.
Small cell lung cancer is the most aggressive tumor among lung cancers and has a greater tendency to be widely disseminated by the time of diagnosis. Without treatment, the median...
- DNA Ploidy Study in 1,673 Fresh Solid Tumors
-
Kim MJ, Kim HK, Chae YS, Yeom BW, Kim IS
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1279-1293.
PURPOSE: To evaluate the possible role of DNA content abnomrality in solid tumors as a diagnostic indicator in Korean patients, the incidence of aneuploidy in the major organs were analyzed...
- Prognostic Factor Analysis of Aggressive Non - Hodgkin's Lymphoma Based on International Prognostic Index Model
-
Ryu MH, Park YI, Kim HK, Lee DH, Jeong JY, Kim DW, Na II, Kim JH, Lee SH, Heo DS, Bang YJ, Park SY, Kim BK, Kim NK
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1269-1278.
PURPOSE: International Prognostic Index Model (IPIM) in aggressive non-Hodgkin's lymphoma was published and accepted generally as a better predictive model for prognosis. This study was undertaken to identify prognostic factors...
- Strain - Specific Differences in Radiation - Induced Apoptosis in Murine Tissues
-
Seong J, Kim SH, Lee WJ, Suh CO, Min JS
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1259-1268.
PURPOSE: To characterize strain-specific differences in radiation response in murine tissues with different radiosensitivity. MATERIALS AND METHODS: Six-week old male mice of 2 strains, C57Bl/6J and C3H/HeJ, were given whole body...
- Granisetron in the Prevention of Nausea and Vomiting in Patients Receiving Platinum - Containing Chemotherapy
-
Kim WS, Kim SY, Cho KS, Kim JH, Yoon HJ
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1249-1258.
PURPOSE: In gastric cancer, metastasis to the paraaortic lymph nodes had been regarded as an incurable factor, but many cases of long term survival have been reported with dissection of...
- A Comparison of the Acute Antiemetic Effect of Tropisetron with Ondansetron in Patients Receiving Cisplatin
-
Cho ST, Hwang BK, Kim CK, Ko BM, Bae SH, Bong JD, Lee CW, Park SK, Won JH, Baick SH, Hong DS, Park HS
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1240-1248.
PURPOSE: Tropisetron, a new specific 5-hydroxytryptamine3 (5-HT3) receptor antagonist, is an effective antiemetic agent in the control of chemotherapy induced emesis with a long half life and bioavailablity. We compared...
- Extraperitoneal Laparoscopic Pelvic Lymph Node Dissection in the Staging of Prostate Carcinoma
-
Lee KS, Oh W, Kim SJ, Chun SS, Kim DK, Lee SW, Choi HY, Chai SE
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1231-1239.
PURPOSE: Diagnostic sampling of pelvic lymph nodes is generally accepted as the optimal procedure for evaluating the metastatic status of locally curable prostate carcinoma. It is usually done by open...
- The Significance of Urinary Nuclear Matrix Protein ( NMP22 ) Measurement in Patients with transitional Cell Carcinoma of the Bladder
-
Jang SH, Choi HR, Shim BS, Kwon SW
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1227-1230.
PURPOSE: The objective of this study was to evaluate an immunoassay for urinary nuclear matrix protein (NMP22) as an indicator for transitional cell carcinoma of the bladder. MATERIALS AND METHODS:...
- The Clinical Usefulness of Membranous E-cadherin in Transitional Cell Carcinoma of the Bladder
-
Oh BR, Nah GJ, Kim SJ, Sim JH, Kwon DD, Park KS, Ryu SB, Park YI
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1219-1226.
PURPOSE: E-cadherin, a cell adhesive molecule that plays a diverse role in cell-cell and cell-matrix interaction, is essential for maintaining epithelial intercellular adhesion and acts particularly as a suppressor of...
- Bcl-2 Expression in Endometrial Hyperplasia and Carcinoma
-
Kim JH, Koh CW, Huh JY, Kim BH, Kong HS, Na JH, Kim YN, Kim YT, Nam JH
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1207-1218.
PURPOSE: To speculate the role of bcl-2 protooncogene in endometrial carcinogenesis by determination of the expression of bcl-2 in endometrial hyperplasia and carcinoma. MATERIALS AND METHODS: We studied bcl-2 expression...
- Cytologic Screening History of 249 Patients with Cervical Cancer
-
Kim JW, Kang SB, Seo DK, Choi SH, Lee CM, Kim YB, Park NH, Song YS, Kang SB, Lee HP
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1198-1206.
PURPOSE: Cervical neoplasias are known to be preventable. But the outcome of our efforts for early detection in Korea is disappointing. This study was undertaken to determine the level of...
- Integration of HPV and the Antibody Respones to HPV Proteins in Patients with Cervical Cancer
-
Lee JM, Kim SJ, Park JS, Namkoong S, Kim CJ, Park TC, Um SJ
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1184-1197.
PURPOSE: HPV (human papillomavirus) are known as the major causative agent for development of cervical cancer. High-risk HPVs, especially HPV-16 /18 DNA, are often found to be integrated into the...
- Treatment of Hepatic Metastasis of Colorectal Cancer: A Retrospective Analysis of the Outcome in 99 Patients
-
Kim JC, Kim CN, Yu CS, Lee HI, Kim SW, Lee JH, Kim WK, Kang GH, Lee MK
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1175-1183.
PURPOSE: Among various modalities of treatment in hepatic metastasis of colorectal cancer, hepatic resection has been proven to be the most effective treatment. This analysis was intended to determine important...
- The Effect of the Degree of Tumor Necrosis on Survival in Patients with Hepatocellular carcinoma Treated with Curative Resection Following Preoperative Transcatheter Arterial Therapy
-
Lee CM, Yoon DS, Kwon SW, Chi HS, Kim BR
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1168-1174.
PURPOSE: To investigate the effect of patient and tumor factors on the degree of tumor necrosis and the effect of the degree of the tumor necrosis on the survival in...
- Transarterial Chemoembolization ( TACE ) for Hepatocellular carcinoma: Comparison of Adriamycin alone vs . Cisplatin alone vs . Adriamycin + Cisplatin
-
Lee JA, Park KC, Kim BS, Do YS, Lim D, Park TS, Kim CM, Lee JO, Yun TK
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1156-1167.
PURPOSE: Although transarterial chemoembolization (TACE) has been widely used for the treatment of unresectable hepatocellular carcinoma, it has not been determined yet which chemotherapeutic agents were best for TACE. To...
- Study of Bone Marrow Micrometastases in Breast Cancer Patient
-
Chung SH, Yoon JH, Jegal YJ
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1147-1155.
PURPOSE: To determine accurately the extent of the disease and risk of recurrence is important in enhancing the therapeutic success rate of breast cancer. Primary tumor state and axillary node...
- The Predicition of Axillary Lymph Node Metastasis in T1 Breast Cancer
-
Kim JW, Koo JY, Lee HD, Jung WH
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1140-1146.
PURPOSE: The axillary lymph node status is the most important prognostic factor in breast cancer. The axillary node dissection is usually performed in infiltrating brcast cancer for the information of...
- Status of Bcl-2 expression and Its Relationship to the Other Prognostic Factors in Breast Cancer
-
Roh GY, Shin DH, Park YL, Shin JH, Kim HD, Kim YS, Han WK, Keum JS, Kim MS, Kong G, Kim MS
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1131-1139.
PURPOSE: There are several well-established prognostic factors to predict the course of breast cancer. Recently, a new category of genes that control the process of programmed cell death, also called...
- The Expression of c-erbB-2 and CD44 Gene in Breast Cancer
-
Heo JH, Kim YG, Kim SH, Lee JH
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1119-1130.
PURPOSE: There are some controversial opinions on the prognostic value of metastasis- associated tumor markers in breast cancer. Out of them, the overexpression of c-erbB-2 proto-oncogene or CD44 gene has...
- Concomitant Boost Radiotherapy for Stage 3 Non - Small Cell Lung Cancer
-
Shin KH, Park CI, Shim YS, Bang YJ, Han SK
- J Korean Cancer Assoc.
- 1998 Dec;30(6):1110-1118.
PURPOSE: This study was undertaken to evaluate the treatment outcome and side effects of accelerated radiotherapy (RT) using concomitant boost for stage III non-small cell lung cancer (NSCLC). METHODS: Between...
